Back to JPMORGAN CHASE & CO JPMORGAN CHASE & CO

TLXTLX
4 quarters

Position history for JPMORGAN CHASE & COJPMORGAN CHASE & CO's holdings in TELIX PHARMACEUTICAL LTD

JPMORGAN CHASE & CO holds 77,538 shares of TLX (TELIX PHARMACEUTICAL LTD), worth $876,185 as of 2026-Q2. The position was increased (+35.2% shares).

Current Value

$876,185

Current Shares

77,538

Total Value Change

+$390,891

Total Shares Change

+26,828

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
77,538
+35.2%
$876,1850.0%$11.53
22
2026-Q1
Decreased
57,348
-22.9%
$513,8380.0%$6.97
0
2025-Q4
Increased
74,368
+46.6%
$557,0160.0%$7.75
23
2025-Q3
New
50,710
-
$485,2940.0%$9.89
37

Other major holders of TLX: FMR LLC, LAZARD ASSET MANAGEMENT LLC, Private Advisor Group, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used